Cargando…
Targeting the Serine Pathway: A Promising Approach against Tuberculosis? †
Tuberculosis is still the leading cause of death by a single infectious agent. Effective chemotherapy has been used and improved since the 1950s, but strains resistant to this therapy and most antibacterial drugs on the market are emerging. Only 10 new drugs are in clinical trials, and two of them h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630544/ https://www.ncbi.nlm.nih.gov/pubmed/31052291 http://dx.doi.org/10.3390/ph12020066 |